Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA Moves Homeopathic Drug Enforcement To Risk-Based Approach

Executive Summary

Products with routes of administration other than oral and topical or intended to be used for the prevention or treatment of serious or life-threatening diseases and conditions will be among those prioritized for enforcement and "regulatory actions," draft guidance notes.

Advertisement

Related Content

Homeopathic Industry Loses Longtime Leader And Advocate, Jack Borneman
OTC Homeopathy Group Revises Label Disclaimers In Light Of FTC Scrutiny
OTC Homeopathy Group Revises Label Disclaimers In Light Of FTC Scrutiny
OTC Homeopathic Market Could Shrink Under US FDA Risk-Based Oversight, Trade Groups Say
OTC Homeopathic Market Could Shrink Under US FDA Risk-Based Oversight, Trade Groups Say
FTC Homeopathic Disclaimer Policy Should Prompt FDA Changes – Advocacy Group
OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC
FDA Examination Of Homeopathic Regulation Looks Beyond Safety History
Inspection, AERs Prompt Hyland's Teething Tablets Recall
Zicam Lawsuits Multiply, But Matrixx Is Confident History Will Repeat Itself

Topics

Advertisement
UsernamePublicRestriction

Register

PS122169

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel